Analysis of polyamines as markers of (patho)physiological conditions

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 781, Issue 1-2, 2002, Pages 107-149

  Teti, Diana ^a   Visalli, Maria ^a   McNair, Harold ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

Pathophysiological conditions; Polyamines; Reviews

Indexed keywords

BIOASSAY; BIOSYNTHESIS; DIAGNOSIS; ENZYMES; METABOLISM; PATHOLOGY;

POLYAMINES;

PHYSIOLOGY;

BIOCHEMICAL MARKER; CADAVERINE; ENZYME; POLYAMINE; PUTRESCINE; SPERMIDINE; SPERMINE; BIOLOGICAL MARKER;

ANALYTIC METHOD; BACTERIUM; CAPILLARY ELECTROPHORESIS; CATABOLISM; CELL DIFFERENTIATION; CELL FUNCTION; CELL HYPERPLASIA; CELL LEVEL; CELL PROLIFERATION; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; CHROMATOGRAPHY; DIAGNOSTIC VALUE; DISEASE MODEL; ELECTRIC POTENTIAL; ELECTROPHORESIS; GAS CHROMATOGRAPHY; GASTROINTESTINAL TRACT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMEOSTASIS; HUMAN; IMMUNOASSAY; MASS SPECTROMETRY; NONHUMAN; PAPER CHROMATOGRAPHY; PAPER ELECTROPHORESIS; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYAMINE METABOLISM; POLYAMINE SYNTHESIS; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; REVIEW; SECOND MESSENGER; THIN LAYER CHROMATOGRAPHY; TISSUE REGENERATION; TUMOR GROWTH; GENERAL ASPECTS OF DISEASE; METABOLISM; METHODOLOGY;

ANIMALIA;

BIOLOGICAL MARKERS; CHROMATOGRAPHY; DISEASE; ELECTROPHORESIS; HUMANS; IMMUNOASSAY; POLYAMINES;

EID: 0037027842     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1570-0232(02)00669-4     Document Type: Review

References (368)

1. Patocka J., Kuehn G.D. Natural polyamines and their biological consequence in mammals. Acta Med. (Hradec Kralove). 43:2000;119.
2. Goyns M.H. The role of polyamines in animal cell physiology. J. Theor. Biol. 97:1982;577.
3. Tabor C.W., Tabor H. Polyamines in microorganism. Microbiol. Rev. 49:1985;81.
4. Tabor C.W., Tabor H. Polyamines. Annu. Rev. Biochem. 53:1984;749.
5. Pegg A.E. Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. Cancer Res. 48:1988;759.
6. Pegg A.E., McCann P.P. Polyamine metabolism and function. Am. J. Physiol. 243:1982;C212.
7. Russell D.H., Russell S.D. Relative usefulness of measuring polyamines in serum, plasma, and urine as biochemical markers of cancer. Clin. Chem. 21:1975;860.
8. Brunton V.G., Grant M.H., Wallace H.M. Spermine toxicity and glutathione depletion in BHK-21/C13 cells. Biochem. Pharmacol. 40:1990;1893.
9. Morgan D.M. Polyamines and cellular regulation: perspectives. Biochem. Soc. Trans. 18:1990;1080.
10. Russell D.H. Increased polyamine concentrations in the urine of human cancer patients. Nat. New Biol. 233:1971;144.
11. Romano M., Santacroce M.A., Bonelli P., Cecco L., Cerra M. Differences in polyamine metabolism between carcinomatous and uninvolved human breast tissues. Int. J. Biol. Markers. 1:1986;77.
12. Becciolini A., Porciani S., Lanini A., Balzi M., Cionini L., Bandettini L. Polyamine levels in healthy and tumor tissues of patients with colon adenocarcinoma. Dis. Colon Rectum. 34:1991;167.
13. Berdinskikh N.K., Ignatenko N.A., Zaletok S.P., Ganina K.P., Chomiy V.A. Ornithine decarboxylase activity and polyamine content in adenocarcinomas of human stomach and large intestine. Int. J. Cancer. 47:1991;496.
14. Kurihara H., Matsuzaki S., Yamazaki H., Tsukahara T., Tamura M. Relationship between tissue polyamine levels and malignancy in primary brain tumors. Neurosurgery. 32:1993;372.
15. Russo F., Linsalata M., Giorgio I., Caruso M.L., Armentano R., Di Leo A. Polyamine levels and ODC activity in intestinal-type and diffuse-type gastric carcinoma. Dig. Dis. Sci. 42:1997;576.
16. Sicca E., Gallesio C., Colombatto S., Madon E. Polyamine evaluation in serum and erythrocytes of pediatric patients with neoplasms. Minerva Pediatr. 49:1997;21.
17. Peng A., Zhao S., Zhang X., Zhang C. Clinical evaluation of polyamine assay in diagnosis of malignant ascites. Human Yi Ke Da Xue Xue Bao. 22:1997;59.
18. Kubo S., Tamori A., Nishiguchi S., Omura T., Kinoshita H., Hirohashi K., Kuroki T., Otani S. Relationship of polyamine metabolism to degree of malignancy of human hepatocellular carcinoma. Oncol. Rep. 5:1998;1385.
19. Leveque J., Burtin F., Catros-Quemener V., Havouis R., Moulinoux J.P. The gastrointestinal polyamine source depletion enhances DFMO induced polyamine depletion in MCF-7 human breast cancer cells in vivo. Anticancer Res. 18:1998;2663.
20. Meyskens F.L. Jr., Gerner E.W., Emerson S., Pelot D., Durbin T., Doyle K., Lagerberg W. Effect of alpha-difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention. J. Natl. Cancer Inst. 90:1998;1212.
21. O'Shaughnessy J.A., Demers L.M., Jones S.E., Arseneau J., Khandelwal P., George T., Gersh R., Mauger D., Manni A. Alpha-difluoromethylornithine as treatment for metastatic breast cancer patients. Clin. Cancer Res. 5:1999;3438.
22. Bandopadhyay M., Ganguly A.K. Putrescine, DNA, RNA and protein contents in human uterine, breast and rectal cancer. J. Postgrad. Med. 46:2000;172.
23. Rohn G., Els T., Hell K., Ernestus R.I. Regional distribution of ornithine decarboxylase activity and polyamine levels in experimental cat brain tumors. Neurochem. Int. 39:2001;135.
24. Cohen R.J., Fujiwara K., Holland J.W., McNeal J.E. Polyamines in prostatic epithelial cells and adenocarcinoma; the effects of androgen blockade. Prostate. 49:2001;278.
25. Hobbs C.A., Paul B.A., Gilmour S.K. Deregulation of polyamine biosynthesis alters intrinsic histone acetyltransferase and deacetylase activities in murine skin and tumors. Cancer Res. 62:2002;67.
26. 12-diacetylspermine as indicators of neoplastic diseases. J. Cancer Res. Clin. Oncol. 121:1995;317.
27. 12-diacetylspermine in urine as novel markers of malignancy. J. Cancer Res. Clin. Oncol. 123:1997;539.
28. Russell D.H. Clinical relevance of polyamines. Crit. Rev. Clin. Lab. Sci. 18:1983;261.
29. Russell D.H. Clinical relevance of polyamines as biochemical markers of tumor kinetics. Clin. Chem. 23:1977;22.
30. Maurelli A.T., Fernandez R.E., Bloch C.A., Rode C.K., Fasano A. "Black holes" and bacterial pathogenicity: a large genomic deletion that enhances the virulence of Shigella spp. and enteroinvasive Escherichia coli. Microbiology. 95:1998;3943.
31. Sunil A.D., Silverstein R., Amura C.R., Kielian T., Morrison D.C. Lipopolyamines: novel antiendotoxin compounds that reduce mortality in experimental sepsis caused by gram-negative bacteria. Antimicrob. Agents Chemother. 43:1999;912.
32. Lowe N.J., Breeding J., Russell D. Cutaneous polyamines in psoriasis. Br. J. Dermatol. 107:1982;21.
33. Krueger G.G., Bergstresser P.R., Lowe N.J., Voorhees J.J., Weinstein G.D. Psoriasis. J. Am. Acad. Dermatol. 11:1984;937.
34. 8-bis(gamma-glutamyl)spermidine cross-linking in epidermal-cell envelopes. Comparison of cross-link levels in normal and psoriatic cell envelopes. Biochem. J. 271:1990;305.
35. Kagramanova A.T., Tischenko L.D., Berezov T.T. The ornithine decarboxylase activity of the epidermis in psoriasis as a biochemical index of the hyperproliferative process. Biull. Eksp. Biol. Med. 115:1993;618.
36. Desser H., Hocker P., Weiser M., Bohmel J. The content of unbound polyamines in blood plasma and leukocytes of patients with polycythemia vera. Clin. Chim. Acta. 63:1975;243.
37. Gunnia U.B., Amenta P.S., Seibold J.R., Thomas T.J. Successful treatment of lupus nephritis in MRL-lpr/lpr mice by inhibiting ornithine decarboxylase. Kidney Int. 39:1991;882.
38. Hsu H.C., Thomas T., Seibold J.R., Thomas T.J. Studies on the effects of an ornithine decarboxylase inhibitor on lupus nephritis reveal a post-transcriptional modification of the enzyme. Agents Actions. 39:1993;C204.
39. Brooks W.H. A model for systemic lupus erythematosus based on chromatin disruption by polyamines. Med. Hypotheses. 43:1994;403.
40. Thomas T.J., Gunnia U.B., Seibold J.R., Thomas T. Defective signal-transduction pathways in T-cells from autoimmune MRL-lpr/lpr mice are associated with increased polyamine concentrations. Biochem. J. 311:1995;175.
41. Hsu H.C., Thomas T., Sigal L.H., Thomas T.J. Polyamine-fas interactions: inhibition of polyamine biosynthesis in MRL-lpr/lpr mice is associated with the up-regulation of fas mRNA in thymocytes. Autoimmunity. 29:1999;299.
42. Stabellini G., Mariani G., Pezzetti F., Calastrini C. Direct inhibitory effect of uremic toxins and polyamines on proliferation of VERO culture cells. Exp. Mol. Pathol. 64:1997;147.
43. Galli F., Beninati S., Benedetti S., Lentini A., Canestrari F., Tabilio A., Buoncristiani U. Polymeric protein-polyamine conjugates: a new class of uremic toxins affecting erythropoiesis. Kidney Int. Suppl. 78:2001;S73.
44. Swendseid M.E., Panaqua M., Kopple J.D. Polyamine concentrations in red cells and urine of patients with chronic renal failure. Life Sci. 26:1980;533.
45. Desser H., Kleinberger G., Klaring W.J. Hepatic failure and polyamine levels in blood plasma. RCS Med. Sci. 8:1980;248.
46. Ruggeri P., Purello D'Ambrosio F. Alcoholic cirrhosis and polyamines. Caldarera C.M., Clò C., Guarnieri C., Biomedical Studies of Natural Polyamines. 1986;217 CLUEB, Bologna.
47. Marchesini G., Checchia G.A., Bianchi G.P., et al. Polyamine plasma levels in patients with liver cirrhosis. Ital. J. Gastroenterol. 20:1988;113.
48. Cecco L., Antoniello S., Auletta M., Cerra M., Bonelli P. Pattern and concentration of free and acetylated polyamines in urine of cirrhotic patients. Int. J. Biol. Markers. 7:1992;52.
49. 1-acetylspermidine and putrescine in hepatic tissues of patients with fulminant hepatitis and liver cirrhosis. J. Gastroenterol. 29:1994;159.
50. Arvanitakis S.N., Mangos J.A., McSherry N.R., Rennert O.M., Lapointe D. Role of polyamines in cystic fibrosis. Pediatr. Res. 7:1973;336.
51. Rennert O.M., Fias J., Lapointe D. Methylation of RNA and polyamine metabolism in cystic fibrosis. Mangos J.A., Talamo R.C., Fundamental Problems of Cystic Fibrosis and Related Diseases. 1973;41 Intercontinental Medical Book, New York.
52. Lundgren D.W., Farrell P.M., Di Sant'Agnese P.A. Polyamines alterations in blood of male homozygotes and heterozygotes for cystic fibrosis. Clin. Chim. Acta. 62:1975;357.
53. Cohen L.F., Farrell P.M., Willison J.W., Lundgreen D.W. Localization of spermidine (Spd) and spermine (Spm) in blood of cystic fibrosis (CF) and control subjects. Pediatr. Res. 9:1975;312.
54. Russell D.H., Rosenblum M.G., Beckerman R.C., Durie B.G.M., Taussig L.M., Barnett D.R. Altered polyamine metabolism in cystic fibrosis. Pediatr. Res. 13:1979;1137.
55. Welsh N., Sjoholm A. Polyamines and insulin production in isolated mouse pancreatic islets. Biochem. J. 252:1988;701.
56. Pedersen S.B., Hougaard D.M., Richelsen B. Polyamines in rat adipocytes: their localization and their effects on the insulin receptor binding. Mol. Cell. Endocrinol. 62:1989;161.
57. Mendez J.D., Arreola M.A. Effect of L-arginine on pancreatic arginase activity and polyamines in alloxan treated rats. Biochem. Int. 28:1992;569.
58. Sjoholm A. Role of polyamines in the regulation of proliferation and hormone production by insulin-secreting cells. Am. J. Physiol. 264:1993;C501.
59. Higuchi C.M., Wang W. Comodulation of cellular polyamines and proliferation: biomarker application to colorectal mucosa. J. Cell. Biochem. 57:1995;256.
60. Alhonen L., Parkkinen J.J., Keinanen T., et al. Activation of polyamine catabolism in transgenic rats induces acute pancreatitis. Proc. Natl. Acad. Sci. USA. 97:2000;8290.
61. Krenzner L.T., Tennyson V.M., Miranda A.F. Polyamine metabolism in normal denervated and dystrophic muscle. Campbell R.A., Morris D.R., Bartos D., Daves G.D., Bartos F., Advances in Polyamine Research. Vol. 2:1978;241 Raven Press, New York.
62. Mollica F., Li Volti S., Rapisarda A., Longo G., Pavone L., Vanella A. Increased erythrocytic spermine in Duchenne muscular dystrophy. Pediatr. Res. 14:1980;1196.
63. Russell D.H., Stern L.Z. Altered polyamine excretion in duchenne muscular dystrophy. Neurology. 31:1981;80.
64. Sauro V.S., Klamut H.J., Dick W.F., Oey D.N., Strickland K.P. Ornithine and S-adenosylmethionine decarboxylase activities and polyamine contents in developing muscle tissues and primary cultures of normal and polymyopathic hamsters. Biochem. Cell Biol. 68:1990;1402.
65. Morrison L.D., Kish S.J. Brain polyamine levels are altered in Alzheimer's disease. Neurosci. Lett. 197:1995;5.
66. Seidl R., Beninati S., Cairns N., Singewald N., Risser D., Bavan H., Nemethova M., Lubec G. Polyamines in frontal cortex of patients with Down syndrome and Alzheimer disease. Neurosci. Lett. 206:1996;193.
67. Boffey G.C., Martin G.M. A new solvent system for the thin-layer chromatographic separation of the Dansyl derivatives of some biogenic amines. J. Chromatogr. 90:1974;178.
68. Fleisher J.H., Russell D.H. Estimation of urinary diamines and polyamines by thin-layer chromatography. J. Chromatogr. 110:1975;335.
69. Heby O., Andersson G. Simplified micro-method for the quantitative analysis of putrescine, spermidine and spermine in urine. J. Chromatogr. 145:1978;73.
70. Beyer C., van den Ende A. Improved separation procedure for urinary di- and polyamines by means of thin-layer chromatography. Clin. Chim. Acta. 129:1983;211.
71. Wettlaufer S.H. Quantitation of polyamines using thin-layer chromatography and image analysis. J. Chromatogr. 441:1988;361.
72. Madhubala R. Thin-layer chromatographic method for assaying polyamines. Methods Mol. Biol. 79:1998;131.
73. Brooks J.B., Moore W.E. Gas chromatographic analysis of amine and other compounds produced by several species of Clostridium. J. Microbiol. 15:1969;1433.
74. Russell D.H. Increased polyamine concentrations in the urine of human cancer patients. Nature. 233:1971;144.
75. Slemr J., Beyermann K. Determination of biogenic amines in meat by combined ion-exchange and capillary gas chromatography. J. Chromatogr. 283:1984;241.
76. Denton M.D., Glazer H.S., Walle T., Zellner D.C., Smith T.G. Russell D.H., Polyamines in Normal and Neoplastic Growth. 1973;373 Raven Press, New York.
77. Gehrke C.W., Kuo K.C., Zumwalt R.W., Waalkes T.P. Polyamines in Normal and Neoplastic Growth. 1973;343 Raven Press, New York.
78. Makita M., Yamamoto S., Kono M. Rapid determination of di- and polyamines in human urine by electron capture gas chromatography. Clin. Chim. Acta. 61:1975;403.
79. McGregor R.F., Sharon M.S., Atkinson M., Johnson D.E. An improved isolation procedure for the gas chromatographic analysis of urinary polyamines. Prep. Biochem. 6:1976;403.
80. Beninati S., Sartori C., Argento-Cerù M.P. A new method for qualitative and quantitative determination of di- and polyamines in animal tissues by gas-liquid chromatography. Anal. Biochem. 80:1977;101.
81. Rattenbury J.M., Lax P.M., Blau K., Sandler M. Separation and quantification of urinary di- and polyamines by gas chromatography with electron capture detection. Clin. Chim. Acta. 95:1979;61.
82. Bakowski M.T., Toseland P.A., Wicks J.F., Trounce J.R. A rapid gas chromatographic method for the determination of plasma polyamines and its application to the prediction of tumor response to chemotherapy. Clin. Chim. Acta. 110:1981;273.
83. Yamamoto S., Yokogawa M., Wakamatsu K., Kataoka H., Makita M. Gas chromatographic method for the determination of urinary acetylpolyamines. J. Chromatogr. B. 233:1982;29.
84. Gaget C., Wol E., Heintzelmann B., Wagner J. Separation of the enantiomers of substituted putrescine and cadaverine analogues by gas chromatography on chiral and achiral stationary phases. J. Chromatogr. 395:1987;597.
85. Fujihara S., Nakashima T., Kurogochi Y. Determination of polyamines in human blood by electron-capture gas-liquid chromatography. J. Chromatogr. 277:1983;53.
86. Emonds A., Driessen O. Determination of polyamines in plasma by capillary gas chromatography and some applications. Methods Find. Exp. Clin. Pharmacol. 5:1983;391.
87. Muskiet F.A.J., van den Berg G.A., Kingma A.W., Fremouw-Ottevangers D.C., Halie M.R. Total polyamines and their non-α-amino acid metabolites simultaneously determined in urine by capillary gas chromatography, with nitrogen-phosphorus detector; and some clinical applications. Clin. Chem. 30:1984;687.
88. Yamamoto S., Kobayashi T., Suemoto Y., Makita M. An improved gas chromatographic method for the determination of urinary acetylpolyamines. Chem. Pharm. Bull. 32:1984;1878.
89. Dalene M., Lundh T., Mathiasson L. N-Permethylation of polyamines at trace levels for gas chromatographic analysis. J. Chromatogr. 322:1985;169.
90. Yamamoto S., Suemoto Y., Kobayashi T., Kohda M., Makita M. Determination of free and monoacetylated polyamines in biological materials by gas chromatography with nitrogen-selective detection. Imahori K., Suzuki F., Suzuki O., Bachrach U., Polyamines, Basic and Clinical Aspects. 1985;479 VNU Science Press, Utrecht, The Netherlands.
91. van den Berg G.A., Muskiet F.A.J., Kingma A.W., van der Slik W., Halie M.R. Simultaneous gas-chromatographic determination of free and acetyl-conjugated polyamines in urine. Clin. Chem. 32:1986;1930.
92. Jiang X. Determination of polyamines in urine of normal human and cancer patients by capillary gas chromatography. Biomed. Chromatogr. 4:1990;73.
93. Dorhout B., Kingma A.W., de Hoog E., Muskiet F.A.J. Simultaneous determination of polyamines, N-acetylated polyamines and the polyamine analogues BE-3-3-3 and BE-4-4-4-4 by capillary gas chromatography with nitrogen-phosphorus detection. J. Chromatogr. B. 700:1997;23.
94. Khuhawar M.Y., Memon A.A., Jaipal P.D., Bhanger M.I. Capillary gas chromatographic determination of putrescine and cadaverine in serum of cancer patients using trifluoroacetylacetone as derivatizing reagent. J. Chromatogr. 723:1999;17.
95. Samejima K., Kawase M., Sakamoto S., Okada M., Endo Y. A sensitive fluorimetric method for the determination of aliphatic diamines and polyamines in biological materials by high-speed liquid chromatography. Anal. Biochem. 76:1976;392.
96. Saeki Y., Uehara N., Shirakawa S. Sensitive fluorimetric method for the determination of putrescine, spermidine and spermine by high-performance liquid chromatography and its application to human blood. J. Chromatogr. 145:1978;221.
97. Seiler N., Knodgen B., Eisenbess F. Determination of di- and polyamines by high-performance liquid chromatographic separation of their 5-dimethylaminonaphthalene-1-sulfonyl derivatives. J. Chromatogr. 145:1978;29.
98. Kai M., Ogata T., Haraguchi K., Ohkura Y. High-performance liquid chromatographic determination of free and total polyamines in human serum as fluorescamine derivatives. J. Chromatogr. 163:1979;151.
99. Shipe J.R., Savory J. High-performance liquid chromatographic separation and fluorescence detection of polyamines in plasma and erythrocytes. Ann. Clin. Lab. Sci. 20:1980;128.
100. Milano G., Schneider M., Cambon P., Boublib J.L., Barbe N., Renee N., Lalanne C.M. An improved method for routine analysis of polyamines in biological fluids with a conventional amino acid analyser. J. Clin. Chem. Clin. Biochem. 18:1980;157.
101. Seiler N., Knodgen B. High-performance liquid chromatographic procedure for the simultaneous determination of the natural polyamines and their monoacetyl derivatives. J. Chromatogr. 221:1980;227.
102. Mach M., Kersten H., Kersten W. Measurement of polyamines and their acetylated derivatives in cell extracts and physiological fluids by use of an amino acid analyser. J. Chromatogr. 223:1981;51.
103. Prussak C.A., Russell D.H. Single-step high-performance liquid chromatographic method for the analysis of acetylated polyamines. J. Chromatogr. 229:1982;47.
104. Lin J., Chen-Cheng L. Chromophoric determination of putrescine, spermidine and spermine with dansyl chloride by high-performance liquid chromatography and thin-layer chromatography. J. Chromatogr. 227:1982;369.
105. Brossat B., Straczen J., Belleville F., Nabet P. Determination of free and total polyamines in human serum and urine by ion-pairing high-performance liquid chromatography using a radial compression module. Application to blood polyamine determination in cancer patients treated or not treated with an ornithine decarboxylase inhibitor. J. Chromatogr. 277:1983;87.
106. Russell D.H., Ellingson J.D., Davis T.P. Analysis of polyamines and acetyl derivatives by a single automated amino acid analyser technique. J. Chromatogr. 273:1983;263.
107. Bontemps J., Laschet J., Dandrifosse G. Analysis of dansyl derivatives of di- and polyamines in mouse brain, human serum and duodenal biopsy specimens by high-performance liquid chromatography on a standard reversed-phase column. J. Chromatogr. 311:1984;59.
108. Heideman R.L., Fickling K.B., Walker L.J. Free and total putrescine in cerebrospinal fluid quantified by reversed-phase liquid chromatography. Clin. Chem. 30:1984;1243.
109. Kabra P.M., Lee H.K., Lubich W.P., Marton L.J. Solid-phase extraction and determination of dansylderivatives of unconjugated and acetylated polyamines by reversed-phase liquid chromatography: improved separation systems for polyamines in cerebrospinal fluid, urine and tissue. J. Chromatogr. 380:1986;19.
110. Koski P., Helander I.M., Sarvas M., Vaara M. Analysis of polyamines as their dansyl derivatives by reversed-phase high-performance liquid chromatography. Anal. Biochem. 164:1987;261.
111. Loser C., Wunderlich U., Folsch U. Reversed-phase liquid chromatographic separation and simultaneous fluorimetric detection of polyamines and their monoacetyl derivatives in human and animal urine, serum and tissue samples: an improved, rapid and sensitive method for routine application. J. Chromatogr. 430:1988;249.
112. Verkoelen C.F., Romijn J.C., Schroeder F.H., van Schalkwijk W.P., Splinter T.A.W. Quantitation of polyamines in cultured cells and tissue homogenates by reversed phase high-performance liquid chromatography of their benzoyl derivatives. J. Chromatogr. 426:1988;41.
113. Auvin-Guette C., Rips R. Polyamines and corresponding aminoacids measured together. Chromatographia. 26:1988;60.
114. Sabri M., Soiefer A.I., Kisby G.E., Spencer P.S. Determination of polyamines by precolumn derivatization with 9-fluorenylmethyl chloroformate and reversed-phase high-performance liquid chromatography. J. Neurosci. Methods. 29:1989;27.
115. Maruta K., Teradaira R., Watanabe N., Nagatsu T., Asano M., Yamamoto K., Matsumoto T., Shionoya Y., Fujita K. Simple, sensitive assay of polyamines by high-performance liquid chromatography with electrochemical detection after post-column reaction with immobilized polyamine oxidase. Clin. Chem. 35:1989;1694.
116. Kamei S., Ohkubo A., Saito S., Takagi S. Polyamine detection system for high-performance liquid chromatography involving enzymatic and chemiluminescent reactions. Anal. Chem. 61:1989;1921.
117. Suzuki S., Kobayashi K., Noda J., Suzuki T., Takama K. Simultaneous determination of biogenic amines by reversed-phase high-performance liquid chromatography. J. Chromatogr. 508:1990;225.
118. Maeno Y., Takabe F., Inoue H., Iwasa M. A study on the vital reaction in wounded skin: simultaneous determination of histamine and polyamines in injured rat skin by high-performance liquid chromatography. Forensic Sci. Int. 46:1990;255.
119. Watanabe S., Saito T., Sato S., Nagase S., Ueda S., Tomita M. Investigation of interfering products in the high-performance liquid chromatographic determination of polyamines as benzoyl derivatives. J. Chromatogr. 518:1990;264.
120. Brandsteterova E., Hatrik S., Blanarik I., Marcincinova K. HPLC determination of polyamines in urine. Neoplasma. 38:1991;165.
121. Gerbaut L. Determination of erythrocytic polyamines by reversed-phase liquid chromatography. Clin. Chem. 37:1991;2117.
122. Oefner P.J., Wongyai S., Bonn G. High-performance liquid chromatographic determination of free polyamines in human seminal plasma. Clin. Chim. Acta. 205:1992;11.
123. Kotzabasis K., Christakis-Hampsas M.D., Roubelakis-Angelakis A. A narrow-bore HPLC method for the identification and quantitation of free, conjugated and bound polyamines. Anal. Biochem. 214:1993;484.
124. Hiramatsu K., Kamei S., Sugimoto M., Kinoshita K., Iwasaki K., Kawakita M. An improved method of determining free and acetylated polyamines by HPLC involving an enzyme reactor and an electrochemical detector. J. Biochem. 115:1994;584.
125. Schenkel E., Berlaimont V., Dubois J., Helson-Cambier M., Hanocq M. Improved high-performance liquid chromatographic method for the determination of polyamines as their benzoylated derivatives: application to P388 cancer cells. J. Chromatogr. B. 668:1995;189.
126. Van Eijk H.M.H., Rooyakkers D.R., Detz N.E.P. Automated determination of polyamines by high-performance liquid chromatography with simple sample preparation. J. Chromatogr. A. 115:1996;115.
127. Weiss T., Bernhardt G., Buschauer A., Jauch K., Zirngibl H. High-resolution reversed-phase high-performance liquid chromatography analysis of polyamines and their monoacetyl conjugates by fluorescence detection after derivatization with N-hydroxysuccinimidyl 6-quinolyn carbamate. Anal. Biochem. 247:1997;294.
128. Fu S., Zou X., Wang X., Liu X. Determination of polyamines in human prostate by high-performance liquid chromatography with fluorescence detection. J. Chromatogr. B. 709:1998;297.
129. Hunter K.J., Fairlamb A.H. The determination of polyamines and amino acids by a fluorescamine-HPLC method. Methods Mol. Biol. 79:1998;125.
130. Hunter K.J. A dansyl chloride-HPLC method for the determination of polyamines. Methods Mol. Biol. 79:1998;119.
131. Morgan D.M. Determination of polyamines as their benzoylated derivatives by HPLC. Methods Mol. Biol. 79:1998;111.
132. Aboul-Enein H.Y., Al-Duraibi I.A. Separation of several free polyamines and their acetylated derivatives by ion-pair reversed-phase high-performance liquid chromatography. Biomed. Chromatogr. 12:1998;291.
133. Sadain S.K., Koropchak J.A. Condensation nucleation light scattering detection for biogenic amines separated by ion-exchange chromatography. J. Chromatogr. A. 844:1999;111.
134. Molins-Legua C., Campins-Falco P., Sevillano-Cabeza A., Pedron-Pons M. Urine polyamines determination using dansyl chloride derivatization in solid-phase extraction cartridges and HPLC. Analyst. 124:1999;477.
135. Taibi G., Schiavo M.R., Gueli M.C., Calanni Rindina P., Muratore R., Nicotra C.M.A. Rapid and simultaneous high-performance liquid chromatography assay of polyamines and monoacetylpolyamines in biological specimens. J. Chromatogr. B. 745:2000;431.
136. Venza M., Visalli M., Cicciù D., Teti D. Determination of polyamines in human saliva by high-performance liquid chromatography with fluorescence detection. J. Chromatogr. B. 757:2001;111.
137. Walle T. Gas chromatography-mass spectrometry of di- and polyamines in human urine: identification of monoacetylspermidine as a major metabolic product of spermidine in a patient with acute myelocytic leukaemia. Russell D.H., Polyamines in Normal and Neoplastic Growth. 1973;355 Raven Press, New York.
138. Shipe J.R., Hunt D.F., Savory J. Plasma polyamines determined by negative-ion chemical ionisation/mass spectrometry. Clin. Chem. 25:1979;1564.
139. Ohki T., Saito A., Ohta K., Niwa T., Maeda K., Sakakibara J. Amine metabolite profile of normal and uremic urine using gas chromatography-mass spectrometry. J. Chromatogr. 233:1982;1.
140. Ikuina Y., Bando C., Yoshida M., Yano H., Saitoh Y. ms-681a, b, c, and d, new inhibitors of myosin light chain kinase from Myrothecium sp. II. Physico-chemical properties and structure elucidation. J. Antibiot. (Tokyo). 50:1997;998.
141. Daves G.D., Smith R.G., Valkenburg C.A. Gas chromatographic-mass spectrometric analysis of polyamines and polyamine conjugated. Methods Enzymol. 94:1983;48.
142. Yamamoto S., Iwado A., Hashimoto Y., Aoyama Y., Makita M. Gas chromatographic-mass spectrometry of polyamines as their N-ethyloxycarbonyl derivatives and identification of sym-homospermidine and sym-norspermine in mosses and ferns. J. Chromatogr. 303:1984;99.
143. Van den Berg G.A., Nagel G.T., Muskiet F.A.J. Mass fragmentographic identification of polyamine metabolites in the urine of normal persons and cancer patients, and its relevance to the use of polyamines as tumor markers. J. Chromatogr. 339:1985;223.
144. Noto T., Hasegawa T., Kamimura H., Nakao J., Hashimoto H., Nakajima T. Determination of putrescine in brain tissue using gas chromatography-mass spectrometry. Anal. Biochem. 160:1987;371.
145. Avery M.J., Junk G.A. Procedure for the determination of amines in small urine samples. J. Chromatogr. 420:1987;379.
146. Smith R.G., Daves G.D. Jr. Gas chromatography-mass spectrometry analysis of polyamines using deuterated analogs as internal standards. Biomed. Mass Spectrom. 4:1997;146.
147. Suh J.W., Lee S.H., Chung B.C., Park J. Urinary polyamine evaluation for effective diagnosis of various cancers. J. Chromatogr. B. 688:1997;179.
148. Kim K.R., Paik M.J., Kim J.H., Dong S.W., Jeong D.H. Rapid gas chromatographic profiling and screening of biologically active amines. J. Pharm. Biomed. Anal. 15:1997;1309.
149. Lee S.H., Kim S.O., Lee H., Chung B.C. Estrogens and polyamines in breast cancer: their profiles and values in diseases staging. Cancer Lett. 133:1998;47.
150. Choi M.H., Kim K., Chung B.C. Determination of hair polyamines as N-ethoxycarbonyl-N-pentafluoropropionyl derivatives by gas chromatography-mass spectrometry. J. Chromatogr. A. 897:2000;295.
151. Seiler N. Assay procedures for polyamines in urine, serum and cerebrospinal fluid. Clin. Chem. 23:1977;1519.
152. Russell D.H., Levy C.C., Scimpff S.C., Hawk I.A. Urinary polyamines in cancer patients. Cancer Res. 31:1971;1555.
153. Marton L.J., Russell D.H., Levy C.C. Measurement of putrescine, spermidine and spermine in physiological fluids by use of an amino acid analyser. Clin. Chem. 19:1973;923.
154. Russell D.H., Russell S.D. Relative usefulness of measuring polyamines in serum, plasma and urine as biochemical markers of cancer. Clin. Chem. 21:1975;860.
155. Fujita K., Nagatsu T., Shinpo K., Maruta K., Teradaira R., Nakamura M. Improved analysis for urinary polyamines by use of high-voltage electrophoresis on paper. Clin. Chem. 26:1980;1577.
156. Kanda S., Takahashi M., Nagase S. Fluorimetric assay for polyamines in urine and tissues using electrophoresis on Titan III cellulose acetate. Anal. Biochem. 180:1989;307.
157. Nashabeh W., El Rassi Z. Enzymophoresis of nucleic acids by tandem capillary enzyme reactor-capillary zone electrophoresis. J. Chromatogr. 596:1992;251.
158. Zhang Y., Gomez F.A. On-column derivatization and analysis of amino acids, peptides, and alkylamines by anhydrides using capillary electrophoresis. Electrophoresis. 21:2000;3305.
159. Zhang R., Cooper C.L., Ma Y. Determination of total polyamines in tumor cells by high-performance capillary zone electrophoresis with indirect photometric detection. Anal. Chem. 65:1993;704.
160. Zhou G., Yu Q., Ma Y., Xue J., Zhang Y., Lin B. Determination of polyamines in serum by high-performance capillary zone electrophoresis with indirect ultraviolet detection. J. Chromatogr. A. 717:1995;345.
161. Van der Schans M.J., Reijenga J.C., Everaerts F.M. Quality control of histamine and methacoline in diagnostic solutions with capillary electrophoresis. J. Chromatogr. A. 735:1996;387.
162. Arce L., Rios A., Valcarel M. Direct determination of biogenic amines in wine by integrating continuous flow clean-up and capillary electrophoresis with indirect UV detection. J. Chromatogr. A. 803:1998;249.
163. Ogury S. Electromigration methods for amino acids, biogenic polyamines and aromatic amines. J. Chromatogr. B. 747:2000;1.
164. Bartos D., Campbell R.A., Bartos F., Grettie D.P. Direct determination of polyamines in human serum by radioimmunoassay. Cancer Res. 35:1975;2056.
165. Bartos F., Bartos D., Dolney A.M., Grettie D.P., Campbell R.A. Radioimmunoassay of spermidine in human serum. Res. Commun. Chem. Pathol. Pharmacol. 19:1978;295.
166. Bartos D., Bartos F., Campbell R.A., Grettie D.P., Smejtek P. Antibody to spermine: a natural biological constituent. Science. 208:1980;1178.
167. Garthwaite I., Stead A.D., Rider C.R. Assay of the polyamine spermine by a monoclonal antibody-based ELISA. J. Immunol. Methods. 162:1993;175.
168. Fujiwara K., Araki M., Kitagawa T., Inoue Y. A new enzyme-linked immunosorbent assay (ELISA) for studying immunocytochemical procedures using an antiserum produced against spermidine as a model. Histochemistry. 99:1993;477.
169. Fujiwara K., Kitagawa T. A new enzyme-linked immunosorbent assay (ELISA) for spermidine using glutaraldehyde coupling of the hapten to carrier-coated microtiter plates. J. Biochem. 114:1993;708.
170. Catcheside J.A., Stead A.D., Rider C.C. Production and characterization of a monoclonal antibody specific for the polyamine spermidine and its application in ELISA. Hybridoma. 15:1996;199.
171. Hallak A., Rosenberg R., Gilat T., Somjen G.J. Determination of free polyamines in human bile by high-performance liquid chromatography. Clin. Sci. (Lond.). 85:1993;451.
172. Duchen K., Thorell L. Nucleotide and polyamine levels in colostrum and mature milk in relation to maternal atropy and atopic development in the children. Acta Paediatr. 88:1999;1338.
173. Noto T., Hasegawa T., Hashimoto H., Nakajima T. Distribution of putrescine in rat brain measured by gas chromatography-mass spectrometry. J. Neurochem. 48:1987;684.
174. Noto T., Hasegawa T., Hashimoto H., Nakajima T. Assay of 2-hydroxyputrescine in various regions of rat brain by gas chromatography-mass spectrometry. J. Neurochem. 50:1988;464.
175. Pegg A.E., Williams-Ashman H.G. Biosynthesis of putrescine. Morris D.R., Marton L.J., Polyamines in Biology and Medicine. 1981;3 Marcel Decker, New York.
176. Russel D.H. Ornithine decarboxylase may be a multifunctional protein. Adv. Enzyme Regul. 21:1983;201.
177. Kuehn G.D., Atmar V.J. Posttranslational control of ornithine decarboxylase by polyamine-dependent protein kinase. Fed. Proc. 41:1982;3078.
178. Fujita K., Murakami Y., Kameji T., Matsufuji S., Utsunomiya K., Kanamoto R., Hayashi S. Regulation of hepatic ornithine decarboxylase by antizyme and antizyme inhibitor. Adv. Polyamine Res. 4:1983;683.
179. Grillo M.A. Metabolism and function of polyamines. J. Biochem. 17:1985;943.
180. Seiler N., Bolkenius F.N., Rennert O.M. Interconversion, catabolism and elimination of the polyamines. Med. Biol. 59:1981;334.
181. Muskiet F.A.J., Dorhout B., van den Berg G.A., Hessels J. Investigation of polyamine metabolism by high-performance liquid chromatographic and gas chromatographic profiling methods. J. Chromatogr. B. 667:1995;189.
182. Seiler N. Liquid chromatographic methods for assaying polyamines using prechromatographic derivatization. Methods Enzymol. 94:1983;10.
183. 1-acetylspermidine in cultured human lymphocytes. Biochem. J. 188:1980;263.
184. Sugiura T., Hayashi T., Kawai S., Ohno T.J. High-speed liquid chromatographic determination of putrescine, spermidine and spermine. J. Chromatogr. 110:1975;385.
185. Hayashi T., Sugiura T., Kawai S., Ohno T. High-speed liquid chromatographic determination of putrescine, spermidine and spermine in human urine. J. Chromatogr. 145:1978;141.
186. Hwang D.F., Chang S.H., Shiua C.Y., Chai T.J. High-performance liquid chromatographic determination of biogenic amines in fish implicated in food poisoning. J. Chromatogr. B. 693:1997;23.
187. Watanabe N. High performance liquid chromatography of spermidine and spermine using a postcolumn reactor of immobilized polyamine oxidase (Aspergillus terreus) followed by electrochemical detection. Biomed. Chromatogr. 6:1992;1.
188. Velasquez R.D., Brunner G., Varrentrapp M., Tsikas D., Frolich J.C. Helicobacter pylori produces histamine and spermidine. Z. Gastroenterol. 34:1996;116.
189. Fujiwara K., Asada H., Kitagawa T., Yamamoto K., Ito T., Tsuchiya R., Sohda M., Nakamura N., Hara K., Tomonaga Y., Ichimaru M., Takahashi S. Preparation of polyamine antibody and its use in enzyme immunoassay of spermine and spermidine with β-D-galactosidase as a label. J. Immunol. Methods. 61:1983;217.
190. Garthwaite I., Stead A.D., Rider C.C. A monoclonal antibody-based immunoassay for the polyamines spermine and spermidine. Biochem. Soc. Trans. 17:1989;1056.
191. Fujiwara K., Kanetake H., Furukawa K., Masuyama Y., Bai G., Tanimori H., Kitagawa T. Determination of urinary acetylpolyamines by a monoclonal antibody-based enzyme-linked immunosorbent assay (ELISA). J. Biochem. 118:1995;1211.
192. Fujiwara K., Furukawa K., Nakayama E., Shiku H. Production and characterization of monoclonal antibodies against the polyamine spermine: Immunocytochemical localization in rat tissue. Histochemistry. 102:1994;397.
193. 12-diacetylspermin as component commonly occurring in normal human urine. J. Biochem. 117:1995;107.
194. Bachrach U. Polyamines as indicators of disease activity and response to therapy. Bachrach U., Heimer Y.M., The Physiology of Polyamines. Vol. II:1989;235 CRC Press, Boca Raton, FL.
195. 12-diacetylspermine. J. Biochem. 124:1998;244.
196. 12-diacetylspermine in human urine. J. Biochem. 124:1998;231.
197. Hiramatsu K., Miura H., Sugimoto K., Kamei S., Iwasaki K., Kawakita M. Preparation of antibodies highly specific to N1, N8-diacetylspermidine, and development of an enzyme-linked immunosorbent assay (ELISA) system for its sensitive and specific detection. J. Biochem. 121:1997;1134.
198. Janne J., Alhonen L., Leinonen P. Polyamines: from molecular biology to clinical applications. Ann. Med. 23:1991;241.
199. Metcalf B.W., Bey P., Danzin C., Jung M.J., Casara P., Vevert J.P. Catalytic irreversible inhibition of mammalian ornithine decarboxylase (EC 4.1.1.17) by substrate and product analogues. J. Am. Chem. Soc. 100:1978;2551.
200. Williams-Ashman H.G., Schenone A. Methyl glyoxal bis(guanylhydrazone) as a potent inhibitor of mammalian and yeast S-adenosylmethionine decarboxylases. Biochem. Biophys. Res. Commun. 46:1972;288.
201. Mihich E. Current studies with methylglyoxal-bis(guanylhydrazone). Cancer Res. 23:1963;1375.
202. Nicolet T., Scemama J.L., Pradayrol L., Berthelemy P., Seva C., Vaysse N. Putrescine and spermidine uptake is regulated by proliferation and dexamethasone treatment in AR4-2J cells. Int. J. Cancer. 49:1991;577.
203. D'Agostino L., Pignata S., Daniele B., D'Adamo G., Ferraro C., Silvestro G., Tagliaferri P., Contegiacomo A., Gentile R., Tritto G., et al. Polyamine uptake by human colon carcinoma cell line CaCo-2. Digestion. 46:1990;352.
204. Blachier F., Selamnia M., Robert V., M'Rabet-Touil H., Duee P.H. Metabolism of L-arginine through polyamine and nitric oxide synthase pathways in proliferative or differentiated human colon carcinoma cells. Biochim. Biophys. Acta. 1268:1995;255.
205. Stuber E., Alves F., Hocker M., Folsch U.R. Putrescine uptake in rat pancreatic acini: effect of secretagogues and growth factors. Pancreas. 8:1993;433.
206. Aubel C., Chabanon H., Persson L., Thiman L., Ferrara M., Brachet P. Antizyme-dependent and -independent mechanism are responsible for increased spermidine transport in amino acid-restricted human cancer cells. Biochem. Biophys. Res. Commun. 256:1999;646.
207. Gray A.C., Clothier R.H. The use of an in vitro submerged keratinocyte model to predict induction of squamous metaplasia. Toxicol. In Vitro. 15:2001;427.
208. Hohl D., Aeschlimann D., Huber M. In vitro and rapid in situ transglutaminase assays for congenital ichthyoses - a comparative study. J. Invest. Dermatol. 110:1998;268.
209. Aeschlimann D., Kaupp O., Paulsson M. Transglutaminase-catalyzed matrix cross-linking in differentiating cartilage: identification of osteonectin as a major glutaminyl substrate. J. Cell Biol. 129:1995;881.
210. Robinson N.A., Lapic S., Welter J.F., Eckert R.L. S100A11, S100A10, annexin I, desmosomal proteins, small proline-rich proteins, plasminogen activator inhibitor-2, and involucrin are components of the cornified envelope of cultured human epidermal keratinocytes. J. Biol. Chem. 272:1997;12035.
211. Robinson N.A., Eckert R.L. Identification of transglutaminase-reactive residues in S100A11. J. Biol. Chem. 273:1998;2721.
212. Piacentini M., Martinet N., Beninati S., Folk J.E. Free and protein-conjugated polyamines in mouse epidermal cells. Effect of high calcium and retinoic acid. J. Biol. Chem. 263:1988;3790.
213. Piacentini M., Farrace M.G., Imparato M., Piredda L., Autuori F. Polyamine-dependent post-translational modification of proteins in differentiating mouse epidermal cells. J. Invest. Dermatol. 94:1990;694.
214. Takano T., Takigawa M., Suzuki F. Role of polyamines in expression of the differentiated phenotype of chondrocytes: effect of DL-alpha-hydrazino-delta-aminovaleric acid (DL-HAVA), an inhibitor of ornithine decarboxylase, on chondrocytes treated with parathyroid hormone. J. Biochem. (Tokyo). 93:1983;591.
215. Parkkinen J.J., Lammi M.J., Agren U., Tammi M., Keinanen T.A., Hyvonen T., Eloranta T.O. Polyamine-dependent alterations in the structure of microfilaments, Golgi apparatus, endoplasmic reticulum, and proteoglycan synthesis in BHK cells. J. Cell. Biochem. 66:1997;165.
216. Loser C. Polyamines in human and animal milk. Br. J. Nutr. 84:2000;S55.
217. Peulen O., Dandrifosse G. Cyclosporine A inhibits partially spermine-induced differentiation but not cell loss of suckling rat small intestine. Dig. Dis. Sci. 45:2000;750.
218. Gritli-Linde A., Bjorkman U., Delle U., Hultborn R., Johansson B.R., Nannmark U., Linde A. Opposing effects of suramin and DL-alpha-difluoromethylornithine on polyamine metabolism contribute to a synergistic action on B16 melanoma cell growth in vitro. Anticancer Res. 18:1998;863.
219. Seiler N., Duranton B., Gosse F., Raul F. Spermine cytotoxicity to human colon carcinoma-derived cells. Cell Biol. Toxicol. 16:2000;117.
220. Herold G., Besemer F., Rogler D., Rogler G., Stange E.F. Polyamine deficiency impairs proliferation and differentiation of cultured enterocytes (CaCo-2). Z. Gastroenterol. 31:1993;120.
221. Frostesjo L., Heby O. Polyamine depletion up-regulates c-Myc expression, yet induces G(1) arrest and terminal differentiation of F9 teratocarcinoma stem cells. J. Cell. Biochem. 76:1999;143.
222. Antonyak M.A., Singh U.S., Lee D.A., Boehm J.E., Combs C., Zgola M.M., Page R.L., Cerione R.A. Effects of tissue transglutaminase on retinoic acid-induced cellular differentiation and protection against apoptosis. J. Biol. Chem. 276:2001;33582.
223. Porter C.W., Regenass U., Bergeron R.J. Dowling R.H., Fölsch U.R., Löser C., Falk Symposium on Polyamines in the Gastrointestinal Tract. 1992;301 Kluwer, Dordrecht.
224. Jänne J., Alhonen L., Leinonen P. Polyamines: from molecular biology to clinical applications. Ann. Med. 23:1991;241.
225. Marton L.J., Pegg A.E. Polyamines as targets for therapeutic intervention. Annu. Rev. Pharmacol. Toxicol. 35:1995;55.
226. Li H., Meininger C.J., Kelley K.A., Hawker J.R. Jr., Morris S.M. Jr., Wu G. Activities of arginase I and II are limiting for endothelial cell proliferation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282:2002;R64.
227. Wei L.H., Wu G., Morris S.M. Jr., Ignarro L.J. Elevated arginase I expression in rat aortic smooth muscle cells increases cell proliferation. Proc. Natl. Acad. Sci. USA. 98:2001;9260.
228. Ray R.M., McCormack S.A., Johnson L.R. Polyamine depletion arrests growth of IEC-6 and Caco-2 cells by different mechanisms. Am. J. Physiol. Gastrointest. Liver Physiol. 281:2001;G37.
229. Scorcioni F., Corti A., Davalli P., Astancolle S., Bettuzzi S. Manipulation of the expression of regulatory genes of polyamine metabolism results in specific alterations of the cell-cycle progression. Biochem. J. 354:2001;217.
230. Bettuzzi S., Davalli P., Astancolle S., Pinna C., Roncaglia R., Boraldi F., Tiozzo R., Sharrad M., Corti A. Coordinate changes of polyamine metabolism regulatory proteins during the cell cycle of normal human dermal fibroblasts. FEBS Lett. 446:1999;18.
231. Murakami Y., Fujita K., Kameji T., Hayashi S. Accumulation of ornithine decarboxylase-antizyme complex in HMOA cells. Biochem. J. 225:1985;689.
232. Fredlund J.O., Johansson M.C., Dahlberg E., Oredsson S.M. Ornithine decarboxylase and S-adenosylmethionine decarboxylase expression during the cell cycle of Chinese hamster ovary cells. Exp. Cell Res. 216:1995;86.
233. Laitinen J., Stenius K., Eloranta T.O., Holtta E. Polyamines may regulate S-phase progression but not the dynamic changes of chromatin during the cell cycle. J. Cell. Biochem. 68:1998;200.
234. Heby O., Marton L.J., Gray J.W., Lindl P.A., Wilson C.B. Bierring F., Proc. 9th Nord. Soc. Cell Biol. 1976;155 Odense University Press, Odense.
235. Fredlund J.O., Oredsson S.M. Ordered cell cycle phase perturbations in Chinese hamster ovary cells treated with an S-adenosylmethionine decarboxylase inhibitor. Eur. J. Biochem. 249:1997;232.
236. Oredsson S.M., Gray J.W., Marton L.J. Progressive increase in polyamine levels in 9L cells in vitro during the cell cycle: comparison between cells isolated by centrifugal elutriation and cells grown in synchrony. Cell Tissue Kinet. 17:1984;437.
237. Heby O., Sarna G.P., Marton L.J., Omine M., Perrey S., Russell D.H. Polyamine content of AKR leukemic cells in relation to the cell cycle. Cancer Res. 33:1973;2959.
238. Gerner E.W., Russell D.H. The relationship between polyamine accumulation and DNA replication in synchronized Chinese hamster ovary cells after heat shock. Cancer Res. 37:1977;482.
239. Alm K., Berntsson P.S., Kramer D.L., Porter C.W., Oredsson S.M. Treatment of cells with the polyamine analog N, N11-diethylnorspermine retards S phase progression within one cell cycle. Eur. J. Biochem. 267:2000;4157.
240. Shantz L.M., Pegg A.E. Translational regulation of ornithine decarboxylase and other enzymes of the polyamine pathway. Int. J. Biochem. Cell Biol. 31:1999;107.
241. Chen Y., Kramer D.L., Diagelman P., Vujcic S., Porter C.W. Apoptotic signaling in polyamine analogue-treated SK-MEL-28 human melanoma cells. Cancer Res. 61:2001;6437.
242. Kramer D.L., Fogel-Petrovic M., Diegelman P., Cooley J.M., Bernacki R.J., McManis J.S., Bergeron R.J., Porter C.W. Effects of novel spermine analogues on cell cycle progression and apoptosis in MALME-3M human melanoma cells. Cancer Res. 57:1997;5521.
243. Kramer D.L., Vujcic S., Diegelman P., Alderfer J., Miller J.T., Black J.D., Bergeron R.J., Porter C.W. Polyamine analogue induction of the p53-p21 WAF1/CIP1-Rb pathway and G1 arrest in human melanoma cells. Cancer Res. 59:1999;1278.
244. Kramer D.L., Chang B.D., Chen Y., Diegelman P., Alm K., Black A.R., Roninson I.B., Porter C.W. Polyamine depletion in human melanoma cells leads to G1 arrest associated with induction of p21 WAF1/CIP1/SDI1, changes in the expression of p21-regulated genes, and a senescence-like phenotype. Cancer Res. 61:2001;7754.
245. Choi S.H., Kim S.W., Choi D.H., Min B.H., Chun B.G. Polyamine-depletion induces p27Kip1 and enhances dexamethasone-induced G1 arrest and apoptosis in human T lymphoblastic leukemia cells. Leuk. Res. 24:2000;119.
246. 2 cells by the polyamine analogue N1, N12-bis(ethyl)spermine is preceded by a reduction in MYC oncoprotein levels. J. Cell. Physiol. 174:1998;380.
247. Redman C., Xu M.J., Peng Y.M., Scott J.A., Payne C., Clark L.C., Nelson M.A. Involvement of polyamines in selenomethionine induced apoptosis and mitotic alterations in human tumor cells. Carcinogenesis. 18:1997;1195.
248. Mank-Seymour A.R., Murray T.R., Berkey K.A., Xiao L., Kern S., Casero R.A. Jr. Two active copies of the X-linked gene spermidine/spermine N1-acetyltransferase (SSAT) in a female lung cancer cell line are associated with an increase in sensitivity to an antitumor polyamine analogue. Clin. Cancer Res. 4:1998;2003.
249. Stefanelli C., Bonavita F., Stanic' I., Pignatti C., Flamigni F., Guarnieri C., Caldarera C.M. Spermine triggers the activation of caspase-3 in a cell-free model of apoptosis. FEBS Lett. 451:1999;95.
250. Stefanelli C., Bonavita F., Stanic' I., Mignani M., Facchini A., Pignatti C., Flamigni F., Caldarera C.M. Spermine causes caspase activation in leukaemia cells. FEBS Lett. 437:1998;233.
251. Sakagami H., Fujiwara E., Yokote Y., Akahane K., Asano K., Kochi M., Hara E., Shirahata A. Changes in intracellular concentrations of amino acids and polyamines during the apoptosis of HL-60 cells. Anticancer Res. 20:2000;265.
252. Trubiani O., Pieri C., Rapino M., Di Primio R. The c-myc gene regulates the polyamine pathway in DMSO-induced apoptosis. Cell Prolif. 32:1999;119.
253. Nitta T., Igarashi K., Yamashita A., Yamamoto M., Yamamoto N. Involvement of polyamines in B cell receptor-mediated apoptosis: spermine functions as a negative modulator. Exp. Cell Res. 265:2001;174.
254. Wallace H.M., Duthie J., Evans D.M., Lamond S., Nicoll K.M., Heys S.D. Alterations in polyamine catabolic enzymes in human breast cancer tissue. Clin. Cancer Res. 6:2000;3657.
255. Ha H.C., Woster P.M., Yager J.D., Casero R.A. Jr. The role of polyamine catabolism in polyamine analogue-induced programmed cell death. Proc. Natl. Acad. Sci. USA. 94:1997;11557.
256. Dai H., Kramer D.L., Yang C., Murti K.G., Porter C.W., Cleveland J.L. The polyamine oxidase inhibitor MDL-72,527 selectively induces apoptosis of transformed hematopoietic cells through lysosomotropic effects. Cancer Res. 59:1999;4944.
257. Harari P.M., Pickart M.A., Contreras L., Petereit D.G., Basu H.S., Marton L.J. Slowing proliferation in head and neck tumors: in vitro growth inhibitory effects of the polyamine analog BE-4-4-4-4 in human squamous cell carcinomas. Int. J. Radiat. Oncol. Biol. Phys. 32:1995;687.
258. Bardocz S., Sakhiri M., Pusztai A., Maguire N.M., Lin P.K. Effect of three novel polyamine oxa-analogues (MTR-OSPD, DIP-SPN and APPO-TFA) on the growth and proliferation of Swiss 3T3 cells. Int. J. Biochem. Cell Biol. 28:1996;697.
259. McCloskey D.E., Yang J., Woster P.M., Davidson N.E., Casero R.A. Jr. Polyamine analogue induction of programmed cell death in human lung tumor cells. Clin. Cancer Res. 2:1996;441.
260. Jeffers L., Church D., Basu H., Marton L., Wilding G. Effects of the polyamine analogues BE-4-4-4-4, BE-3-7-3, and BE-3-3-3 on the proliferation of three prostate cancer cell lines. Cancer Chemother. Pharmacol. 40:1997;172.
261. Kaneko H., Hibasami H., Mori K., Kawarada Y., Nakashima K. Apoptosis induction in human breast cancer MRK-nu-1 cells by a polyamine synthesis inhibitor, methylglyoxalbis(cyclopentylaminohydrazone) (MGBCP). Anticancer Res. 18:1998;891.
262. Schipper R.G., Deli G., Deloyer P., Lange W.P., Schalken J.A., Verhofstad A.A. Antitumor activity of the polyamine analog N(1), N(11)-diethylnorspermine against human prostate carcinoma cells. Prostate. 44:2000;313.
263. McCloskey D.E., Woster P.M., Casero R.A. Jr., Davidson N.E. Effects of the polyamine analogues N1-ethyl-N11-((cyclopropyl)methyl)-4,8-diazaundecane and N1-ethyl-N11-((cycloheptyl)methyl)-4,8-diazaundecane in human prostate cancer cells. Clin. Cancer Res. 6:2000;17.
264. Reddy V.K., Sarkar A., Valasinas A., Marton L.J., Basu H.S., Frydman B. Cis-Unsaturated analogues 3,8,13,18,23-pentaazapentacosane BE-4-4-4-4): synthesis and growth inhibitory effects on human prostate cancer cell lines. J. Med. Chem. 44:2001;404.
265. Bergeron R.J., Muller R., Huang G., McManis J.S., Algee S.E., Yao H., Weimar W.R., Wiegand J. Synthesis and evaluation of hydroxylated polyamine analogues as antiproliferatives. J. Med. Chem. 44:2001;2451.
266. Koenig H., Goldstone A.D., Lu C.Y., Iqbal Z., Fan C.C., Trout J.J. Eachrack U., Heimez Y.M., The Physiology of Polyamines. Vol. I:1989;57 CRC Press, Boca Raton, FL.
267. Paschen W. Polyamine metabolism in reversible cerebral ischemia. Cerebrovasc. Brain Metab. Rev. 4:1992;59.
268. Bazzani C., Genedani S., Tagliavini S., Piccinini G., Bertolini A. Treatment with polyamine synthesis inhibitors reduces the positive inotropic effect of ouabain, noradrenaline and calcium. Pharmacol. Res. Commun. 20:1988;23.
269. Thomas T., Gunnia U.B., Yurkow E.J., Seibold J.R., Thomas T.J. Inhibition of calcium signalling in murine splenocytes by polyamines: differential effects on CD4 and CD8 T-cells. Biochem. J. 291:1993;375.
270. Hermann M.D., Reuveny E., Narahashi T. The effect of polyamines on voltage-activated calcium channels in mouse neuroblastoma cells. J. Physiol. 462:1993;645.
271. 2+-ATPase. J. Biol. Chem. 266:1991;5736.
272. 2+ pump. Mol. Cell. Biochem. 199:1999;7.
273. 2+ transport by endoplasmic reticulum and mitochondria in permeabilized pancreatic islets. Diabetes. 40:1991;323.
274. 2+ transport. Biochem. J. 286:1992;597.
275. Rustenbeck I., Eggers G., Reiter H., Munster W., Lenzen S. Polyamine modulation of mitochondrial calcium transport. I. Stimulatory and inhibitory effects of aliphatic polyamines, aminoglucosides and other polyamine analogues on mitochondrial calcium uptake. Biochem. Pharmacol. 56:1998;977.
276. Rustenbeck I., Loptien D., Fricke K., Lenzen S., Reiter H. Polyamine modulation of mitochondrial calcium transport. II. Inhibition of mitochondrial permeability transition by aliphatic polyamines but not by aminoglucosides. Biochem. Pharmacol. 56:1998;987.
277. 2+ transients. Biochim. Biophys. Acta. 1366:1998;5.
278. Meers P., Hong K., Bentz J., Papahadjopoulos D. Spermine as a modulator of membrane fusion: interactions with acidic phospholipids. Biochemistry. 25:1986;3109.
279. Mernissi-Arifi K., Imbs I., Schlewer G., Spiess B. Complexation of spermine and spermidine by myo-inositol 1,4,5-tris(phosphate) and related compounds: biological significance. Biochim. Biophys. Acta. 1289:1996;404.
280. 2+ system in solution. J. Inorg. Biochem. 84:2001;107.
281. Huang C., Liang N.C. Increase in cytoskeletal actin induced by inositol 1,4-bisphosphate in saponin-permeated pig platelets. Cell Biol. Int. 18:1994;797.
282. Saumon G., Martet G. Spermine increases the active and passive transport across the alveolar epithelium in situ: effect of thiol reagents. Pflug. Arch. Eur. J. Physiol. 441:2001;559.
283. Said S.I., Berisha H.I., Pakbaz H. Excitotoxicity in the lung: N-methyl-D-aspartate-induced, nitric oxide-dependent, pulmonary edema is attenuated by vasoactive intestinal peptide and by inhibitors of poly(ADP-ribose) polymerase. Proc. Natl. Acad. Sci. USA. 93:1996;4688.
284. Wang J.Y., Johnson L.R. Role of transglutaminase and protein cross-linking in the repair of mucosal stress erosions. Am. J. Physiol. 262:1992;G818.
285. Wang J.Y., Johnson L.R. Expression of protooncogenes c-fos and c-myc in healing of gastric mucosal stress ulcers. Am. J. Physiol. 266:1994;G878.
286. Farriol M., Segovia-Silvestre T., Venereo Y., Orta X. Polyamines in the gastrointestinal tract. Nutr. Hosp. 15:2000;85.
287. Kubo S., Matsui-Yuasa I., Otani S., Morisawa S., Kinoshita H., Sakai K. Effect of splenectomy on liver regeneration and polyamine metabolism after partial hepatectomy. J. Surg. Res. 41:1986;401.
288. Moulinoux J.P., Quemener V., Chambon Y. Evolution of red blood cell polyamine levels in partially hepatectomized rat. Eur. J. Cancer Clin. Oncol. 23:1987;237.
289. Minuk G.Y., Gauthier T., Benarroch A. Changes in serum and hepatic polyamine concentrations after 30%, 70% and 90% partial hepatectomy in rats. Hepatology. 12:1990;542.
290. Beyer H.S., Ellefson M., Stanley M., Zieve L. Inhibition of increases in ornithine decarboxylase and putrescine has no effect on rat liver regeneration. Am. J. Physiol. 262:1992;G677.
291. Ogiso S., Matsumoto T., Nimura Y. The role of polyamines in liver regeneration after hepatectomy with ischemic injury. Surg. Today. 27:1997;833.
292. Tsukamoto T., Kinoshita H., Hirohashi K., Kubo S., Otani S. Human erythrocyte polyamine levels after partial hepatectomy. Hepatogastroenterology. 44:1997;744.
293. Humphreys M.H., Etheredge S.B., Lin S.Y., Ribstein J., Marton L.J. Renal ornithine decarboxylase activity, polyamines, and compensatory renal hypertrophy in the rat. Am. J. Physiol. 255:1988;F270.
294. Tovar A., Sanchez-Capelo A., Cremades A., Penafiel R. An evaluation of the role of polyamines in different models of kidney hypertrophy in mice. Kidney Int. 48:1995;731.
295. Rannels D.E., Addison J.L., Bennett R.A. Increased pulmonary uptake of exogenous polyamines after unilateral pneumonectomy. Am. J. Physiol. 250:1986;E435.
296. Karl H.W., Russo L.A., Rannels D.E. Inflation-associated increases in lung polyamine uptake: role of altered pulmonary vascular flow. Am. J. Physiol. 257:1989;E729.
297. Russo L.A., Rannels S.R., Laslow K.S., Rannels D.E. Stretch-related changes in lung cAMP after partial pneumonectomy. Am. J. Physiol. 257:1989;E261.
298. Uhal B.D., Hess G.D., Rannels D.E. Density-independent isolation of type II pneumocytes after partial pneumonectomy. Am. J. Physiol. 256:1989;C515.
299. Nishiguchi S., Kuroki T., Nakajima S., et al. Effects of putrescine on D-galactosamine-induced acute liver failure in rats. Hepatology. 12:1990;348.
300. Diehl A.M., Abdo S., Brown N. Supplemental putrescine reversed ethanol-associated inhibition of liver regeneration. Hepatology. 12:1990;633.
301. Macintosh E., Gauthier T., Pettigrew N., Minuk G. Liver regeneration and the effect of exogenous putrescine on regenerative activity after partial hepatectomy in cirrhotic rats. Hepatology. 16:1992;1428.
302. Theocharis S.E., Margeli A.P., Spiliopoulou C., Skaltsas S.D., Koutselinis A. Putrescine administration reversed cadmium-associated inhibition of liver regeneration. Dig. Dis. Sci. 43:1998;1732.
303. Nishiguchi S., Otani S., Matsui-Yuasa I., Morisawa S., Monna T., Kuroki T., Kobayashi K., Yamamoto S. Inhibition by interferon (alpha+beta) of mouse liver regeneration and its reversal by putrescine. FEBS Lett. 205:1986;61.
304. 2b administration on rat liver regeneration after partial hepatectomy. Dig. Dis. Sci. 42:1997;1981.
305. Fujiwara K., Nagoshi S., Ohno A., Hirata K., Ohta Y., Mochida S., Tomiya T., Higashio K., Kurokawa K. Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats. Hepatology. 18:1993;1443.
306. Brandt J.T., Pierce D.A., Fausto N. Ornithine decarboxylase activity and polyamine synthesis during compensatory hypertrophy. Biochim. Biophys. Acta. 279:1972;184.
307. Goldstone A., Koening H., Lu C. Testosterone-dependent sexual dimorphism of the mouse kidney is mediated by polyamines. Biochem. Biophys. Res. Commun. 104:1982;165.
308. Manteuffel-Cymborowska M., Chmurzynska W., Peska M., Grzelakowska-Sztabert B. Arginine and ornithine metabolising enzymes in testosterone-induced hypertrophic mouse kidney. Int. J. Biochem. Cell Biol. 27:1995;287.
309. Berger F.G., Porter C.W. Putrescine does not mediate the androgenic response in mouse kidney. Biochem. Biophys. Res. Commun. 138:1986;771.
310. Pedersen S.B., Flyvbjerg A., Gronbaek H., Richelsen B. Increased ornithine decarboxylase activity in kidneys undergoing hypertrophy in experimental diabetes. Mol. Cell. Endocrinol. 86:1992;67.
311. Van Gend M., Ward L.C., Garrett J.L. Ornithine decarboxylase activity and actin polymerization in testosterone-stimulated mouse kidney. Biochem. Int. 13:1986;13.
312. el-Marjou A., Bankir L., Pierrat D., Trinh-Trang-Tan M.M. Messenger RNA for enzymes of ornithine and polyamine metabolism are selectively underexpressed in kidney of 5/6 nephrectomized rats. Exp. Nephrol. 5:1997;285.
313. Manteuffel-Cymborowska M., Chmurzynska W., Grzelakowska-Sztabert B. Polyamines in testosterone-induced hypertrophic and antifolate-induced hyperplastic mouse kidney. Differential effect of α-difluoromethylornithine. Biochim. Biophys. Acta. 1182:1993;133.
314. Austin H.A., Goldin H., Gaydos D., Preuss H.G. Polyamine metabolism in compensatory renal growth. Kidney Int. 23:1983;581.
315. Sanchez-Capelo A., Penafiel R., Tovar A., Galindo J., Cremades A. Postnatal development of ornithine decarboxylase and polyamines in the mouse kidney. Influence of testosterone. Biol. Neonate. 66:1994;119.
316. Crozat A.A., Palvimo J.J., Julkunen M., Janne O.A. Comparison of androgen regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase gene expression in rodent kidney and accessory sex organs. Endocrinology. 130:1992;1131.
317. Bardocz S. Polyamines in tissue regeneration. Bachrack U., Heimez Y.M., The Physiology of Polyamines. Vol. 1:1989;95 CRC Press, Boca Raton, FL.
318. Mimori K., Mori M., Shiraishi T., Tanaka S., Haraguchi M., Ueo H., Shirasaka C., Akiyoshi T. Expression of ornithine decarboxylase mRNA and c-myc mRNA in breast tumours. Int. J. Oncol. 12:1998;597.
319. Yoshida M., Hayashi H., Taira M., Isono K. Elevated expression of the ornithine decarboxylase gene in human esophageal cancer. Cancer Res. 52:1992;6671.
320. Okuzumi J., Yamane T., Kitao Y., Tokiwa K., Yamaguchi T., Fujita Y., Nishino H., Iwashima A., Takahashi T. Increased mucosal ornithine decarboxylase activity in human gastric cancer. Cancer Res. 51:1991;1448.
321. Guillem J.G., Levy M.F., Hsieh L.L., Johnson M.D., LoGerfo P., Forde K.A., Weinstein I.B. Increased levels of phorbin, c-myc, and ornithine decarboxylase RNAs in human colon cancer. Mol. Carcinog. 3:1990;68.
322. Tamori A., Nishiguchi S., Kuroki T., Seki S., Kobayashi K., Kinoshita H., Otani S. Relationship of ornithine decarboxylase activity and histological findings in human hepatocellular carcinoma. Hepatology. 20:1994;1179.
323. Kubo S., Tamori A., Nishiguchi S., Kinoshita H., Hirohashi K., Kuroki T., Omura T., Otani S. Effect of alcohol abuse on polyamine metabolism in hepatocellular carcinoma and noncancerous hepatic tissue. Surgery. 123:1998;205.
324. Williams-Ashman H.G., Coppoe G.L., Weber G. Imbalance in ornithine metabolism in hepatomas of different growth rates as expressed in formation of putrescine, spermidine, and spermine. Cancer Res. 32:1972;1924.
325. Tabib A., Bachrach U. Role of polyamines in mediating malignant transformation and oncogene expression. Int. J. Biochem. Cell Biol. 31:1999;1289.
326. O'Brien T.G., Megosh L.C., Gilliard G., Soler A.P. Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin. Cancer Res. 57:1997;2630.
327. LaMuraglia G.M., Lacaine F., Malt R.A. High ornithine decarboxylase activity and polyamine levels in human colorectal neoplasia. Ann. Surg. 204:1986;89.
328. Matsuda M., Osafune M., Kotake T., Sonoda T., Sobue K., Nakajima T. Concentrations of polyamines in renal cell carcinoma. Clin. Chim. Acta. 87:1978;93.
329. Lee S.H., Kim S.O., Lee H.D., Chung B.C. Estrogens and polyamines in breast cancer: their profiles and values in disease staging. Cancer Lett. 133:1998;47.
330. Schleiffer R., Duranton B., Gosse F., Hasselmann M., Raul F. Blood polyamine levels after oral ornithine load, a diagnostic marker of hyperproliferative premalignant and malignant stages in a model of colon carcinogenesis. Cancer Detect. Prev. 24:2000;542.
331. Yatin M., Venkataraman G.M., Marcinek R., Ain K.B. Polyamine synthesis and transport inhibition in a human anaplastic thyroid carcinoma cell line in vitro and as xenograft tumors. Thyroid. 9:1999;805.
332. Redgate E.S., Boggs S., Grudziak A., Deutsch M. Polyamines in brain tumor therapy. J. Neurooncol. 25:1995;167.
333. Leveque J., Foucher F., Havouis R., Desury D., Grall J.Y., Moulinoux J.P. Benefits of complete polyamine deprivation in hormone responsive and hormone resistant MCF-7 human breast adenocarcinoma in vivo. Anticancer Res. 20:2000;97.
334. Davidson N.E., Hahm H.A., McCloskey D.E., Woster P.M., Casero R.A. Jr. Clinical aspects of cell death in breast cancer: the polyamine pathway as a new target for treatment. Endocr. Relat. Cancer. 6:1999;69.
335. 11-bis(ethyl)norspermine. Clin. Cancer Res. 5:1999;1638.
336. 11-diethylnorspermine administered by multiple injection or continuous infusion. Clin. Cancer Res. 1:1995;847.
337. Litvak D.A., Papaconstantinou H.T., Ko T.C., Townsend C.M. Jr. A novel cytotoxic agent for human carcinoid tumors. Surgery. 124:1998;1071.
338. Yano Y., Yano T., Uchida M., Murakami A., Ogita M., Ichikawa T., Otani S., Hagiwara K. The inhibitory effect of vitamin E on pulmonary polyamine biosynthesis, cell proliferation and carcinogenesis in mice. Biochim. Biophys. Acta. 1356:1997;35.
339. Sabry I., Matsuzaki S. Daily cycles of putrescine, spermidine, and spermine in the liver, pineal gland, harderian gland, anterior pituitary, and testes of rats kept in LD 12:12. J. Pineal Res. 11:1991;86.
340. Poyhonen M.J., Uusitalo U.M., Kari A., Takala J.A., Alakuijala L.A., Eloranta T.O. Urinary excretion of polyamines: importance of circadian rhythm, age, sex. Menstrual cycle, weight, and creatinine excretion. Am. J. Clin. Nutr. 52:1990;746.
341. Mashige F., Tanaka N., Murakami T., Shimosaka H., Kamei S., Ohkubo A. Clinical usefulness of an enzymatic determination of total urinary polyamines, excluding cadaverine. Clin. Chem. 34:1988;2271.
342. Ploszaj T., Ryniewicz Z., Motyl T. Polyamines in goat's colostrums and milk. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 118:1997;45.
343. Beninati S., Piacentini M., Spinedi A., Autuori F. Urinary polyamine excretion in man: I. Influence of sex and age. Biomedicine. 33:1980;140.
344. Morrison L.D., Becker L., Ang L.C., Kish S.J. Polyamines in human brain: regional distribution and influence of aging. J. Neurochem. 65:1995;636.
345. Morrison L.D., Becker L., Kish S.J. S-Adenosylmethionine decarboxylase in human brain. Regional distribution and influence of aging. Brain Res. Dev. Brain Res. 73:1993;237.
346. Jotova I., Pavlov V., Dimitrov O., Bachrach U. Developmental aspects of polyamine-oxidizing enzyme activities in the mouse kidney. Effect of testosterone. Amino Acids. 17:1999;267.
347. Osterberg S., Rose S., Heby O. Urinary polyamine excretion during the menstrual cycle. Clin. Chem. 24:1978;769.
348. Beninati S., Accardi L., Spinedi A., Piacentini M. Urinary polyamine excretion in man. II. Influence of menstrual cycle. Biomedicine. 33:1980;182.
349. Holinka C.F., Gurpide E. Ornithine decarboxylase activity in human endometrium and endometrial cancer cells. In Vitro Cell. Dev. Biol. 21:1985;697.
350. Fozard J.R., Part M.L., Prakash N.J., Grove J. Inhibition of murine embryonic development by alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase. Eur. J. Pharmacol. 65:1980;379.
351. Oka T., Borellini F. Hayashi S., Ornithine Decarboxylase: Biology, Enzymology and Molecular Genetics. 1989;7 Pergamon Press, New York.
352. Fozard J.R., Part M.L., Prakash N.J., Grove J., Schechter P.J., Sjoerdsma A., Koch-Weser J. L-Ornithine decarboxylase: an essential role in early mammalian embryogenesis. Science. 208:1980;505.
353. Fozaed R. McCann P.P., Pegg A.E., Sjoerdsma A., Inhibition of Polyamine Metabolism: Biological Significance and Basis for New Therapies. 1987;187 Academic Press, Orlando, FL.
354. Hiramatsu Y., Eguchi K., Yonezaw M., Hayase R., Sekeba K. Alteration of red blood cells polyamines during pregnancy and neonatal period. Biol. Neonate. 40:1981;136.
355. Cremades A., Sanchez-Capelo A., Tovar A., Penafiel R. Involvement of polyamines in the contragestational effect of hyperthermia. Life Sci. 57:1995;1343.
356. Streffer C. Metabolic changes during and after hyperthermia. Int. J. Hyperthermia. 1:1985;305.
357. Laszio A. The effects of hyperthermia on mammalian cell structure and function. Cell Prolif. 25:1992;59.
358. Mehrotra P.K., Kitchlu S., Farheen S. Effect of inhibitors of enzymes involved in polyamine biosynthesis pathway on pregnancy in mouse and hamster. Contraception. 57:1998;55.
359. Allen J.C., Smith C.J., Curry M.C., Gaugas J.M. Identification of a thymine inhibitor (chalone) of lymphocyte transformation as a spermine complex. Nature. 267:1977;623.
360. Rijke E.O., Ballieux R.E. Is thymus derived lymphocyte inhibitor a polyamine? Nature. 274:1978;804.
361. Illei G., Morgan D.M.L. Serum polyamine oxidase activity in spontaneous abortion. Br. J. Obstet. Gynaecol. 89:1982;199.
362. Pande S., Mehrotra P.K., Singh S., Pande V.C., Kamboj V.P. Determination of polyamine concentration during embryonic development in the mouse. Med. Sci. Res. 21:1993;759.
363. Kirby D.R.S. Blastocyst-uterine relationship before and during implantation. Blandau R.J., The Biology of the Blastocyst. 1971;393 University Press, Chicago.
364. Shentu J., Zhou H., He Q., Wang L., Fang R. Effects of DL111-IT or combined with RU486 on uterine polyamines biosynthesis in rats during early gestation. Contraception. 63:2001;283.
365. Galliani G., Luzzani F., Colombo G., Conz A., Mistrello L., Assandri A., et al. On the mode of action of a new contragestational agent (DL111-IT). Contraception. 33:1986;263.
366. Ishida H., Iwayama Y., Daikuhara Y. Changes in polyamine metabolism during experimental periodontitis in dog and the role of putrescine in recovery. Arch. Oral Biol. 28:1983;51.
367. Lamster B., Mandella R.M., Zove M., Harper S. The polyamine putrescine, spermidine and spermine in human gingival crevicular fluid. Arch. Oral Biol. 32:1987;329.
368. Venza M., Visalli M., Ruggeri P., Cicciù D., Teti D. Age-related salivary polyamine increase in adolescents wearing orthodontic Ni-Ti archwires. Amino Acids. 22:2002;119.